The UK Medicines and Healthcare Products Regulatory Agency (MHRA), has approved Nuvaxovid, COVID-19 vaccine developed by Novavax, as a vaccine booster for 12 years to 17 years old children. The approval follows a review of the safety, effectiveness, and quality of the COVID-19 vaccine in the age group, and expert advice from the Commission on […]
Continue Reading
The US Food and Drug Administration (FDA) has approved Novavax Inc.’s COVID-19 vaccine as a booster dose for adults to tackle the rapid spread of the COVID-19 virus in the country. The approval from the US FDA is set to reverse Novavax’s shares reverse course, and increase by more than 3 percent. This approval is […]
Continue Reading
The US Centers for Disease Control and Prevention (CDC) has signed off on the use of COVID-19 vaccine by Novavax Inc. for adolescents aged 12 to 17 years. The recommendation also follows the authorization of the US Food and Drug Administration (FDA) for the COVID-19 vaccine for the age group. The Novavax vaccine has received […]
Continue Reading
Novavax, Inc., a biotechnology company to develop and commercializing next-gen vaccines for serious infectious diseases, announced that the Novavax Covid-19 vaccine has received emergency use authorization (EUA) from the Food and Drug Administration (FDA) of the United States. The approval is given to provide a two-dose primary series for active immunization to prevent COVID-19 disease […]
Continue Reading
The advisory of the Food and Drug Administration (FDA) of the United States have voted to recommend the corona virus vaccine developed by Novavax for use in the adult people in the United States, which the company is hoping can possibly become the vaccine shot of choice among some of the vaccine sceptics of the […]
Continue Reading
On Monday, 21st December 2021, the medicine regulator of the European Union have given the authorization to a fifth novel corona virus vaccine for use in the bloc of the 27th member nations, along with granting the authorization for the conditional marketing to the two-dose vaccine made by Novavax, biotechnology in the United States. The […]
Continue Reading
On Wednesday, 27th October 2021, the company ‘Novavax’ has announced the completion of the company’s regulatory submission to the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom for the authority of the company’s novel corona virus vaccine known as NVX-CoV2373, and this has also been marking the very first submission of a […]
Continue Reading
On Thursday, 5th August 2021, the company ‘Novavax’ has delayed the timeline of the company for the purpose of seeking the authorization of the United States for the company’s two-dose novel corona virus vaccine but, it is also expecting to become one of the major distributors to the low-income and medium-income countries in 2021. Previously, […]
Continue Reading